Skip to main content
Figure 6 | Journal of Neuroinflammation

Figure 6

From: The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis

Figure 6

CCL2 expression profile during experimental autoimmune encephalomyelitis (EAE). Mice were immunized with MOG peptide to induce EAE. At the indicated days post-immunization, mice were sacrificed and CCL2 mRNA levels determined in the whole brain. CCL2 expression is seen to rapidly rise and fall between days 9 to 21, showing the highest level at day 14.

Back to article page